Document:

Exhibit 4.1

 

WARRANT AGREEMENT

 

 THIS WARRANT AGREEMENT
(this “Agreement”), dated as of January 19, 2017, is by and between FinTech Acquisition Corp. II, a Delaware
corporation (the “Company”), and Continental Stock Transfer & Trust Company, a New York corporation,
as warrant agent (the “Warrant Agent”) also referred to as the “Transfer Agent”).

 

WHEREAS, the Company has
entered into those certain Unit Subscription Agreements, dated December 23, 2016, with each of FinTech Investor Holdings, LLC,
a Delaware limited liability company (the “Sponsor”) and Cantor Fitzgerald & Co., a New York general
partnership (“Cantor”), pursuant to which the Sponsor and Cantor will purchase an aggregate of 420,000
Units (as defined below) for an aggregate purchase price of $4,200,000 (“Placement Units”), each Unit
consisting of one share of Common Stock (as defined below) (“Placement Shares”) and one-half of one warrant
to purchase one Placement Share (the “Placement Warrants”) of the Company, bearing the legend set forth
in Exhibit B hereto, to be sold simultaneously with the closing of the Offering (as defined below);

 

WHEREAS, the Company is engaged
in an initial public offering (the “Offering”) of units of the Company’s equity securities, each
such unit comprised of one share of Common Stock and one-half of one Public Warrant (as defined below) (the “Public
Units”, and together with the Placement Units, the “Units”) and, in connection therewith,
has determined to issue and deliver up to 8,797,500 Warrants (including up to 1,147,500 warrants that may be issuable upon the
exercise of a forty-five (45) day over-allotment option granted to the underwriters (the “Over-allotment Option”))
to investors in the Offering (the “Public Warrants” and, together with the Placement Warrants, (the “Warrants”),
each whole Warrant evidencing the right of the holder thereof to purchase one share of common stock of the Company, $0.0001 par
value per share (the “Common Stock”), for $11.50 per share, subject to adjustment as described herein;

 

WHEREAS, the Company has
filed with the Securities and Exchange Commission (the “Commission”) a registration statement on Form S-1,
No. 333-215305 (the “Registration Statement”) and prospectus (the “Prospectus”)
under the Securities Act of 1933, as amended (the “Securities Act”), with respect to the Public Units
and the Public Warrants and Common Stock included in the Public Units;

 

WHEREAS, the Company desires
the Warrant Agent to act on behalf of the Company, and the Warrant Agent is willing so to act, in connection with the issuance,
registration, transfer, exchange, redemption and exercise of the Warrants;

 

WHEREAS, the Company desires
to provide for the form and provisions of the Warrants, the terms upon which they shall be issued and exercised, and the respective
rights, duties, obligations and immunities of the Company, the Warrant Agent, and the holders of the Warrants; and

 

WHEREAS, all acts and things
have been done and performed which are necessary to make the Warrants, when executed on behalf of the Company and countersigned
by or on behalf of the Warrant Agent, as provided herein, the valid, binding and legal obligations of the Company, and to authorize
the execution and delivery of this Agreement.

 

NOW, THEREFORE, in consideration
of the mutual agreements herein contained, the parties hereto agree as follows:

 

1. Appointment of Warrant
Agent. The Company hereby appoints the Warrant Agent to act as agent for the Company in connection with the Warrants, and the
Warrant Agent hereby accepts such appointment and agrees to perform the same in accordance with the terms and conditions set forth
in this Agreement.

 

     

     

    

 

	 	2.	Warrants.

 

2.1 Form of Warrant.
Each Warrant shall be issued in registered form only and shall be in substantially the form of Exhibit A hereto, the
provisions of which are incorporated herein and shall be signed by, or bear the original or facsimile signature of, the Chairman
of the Board, President, Chief Executive Officer, Chief Financial Officer, Secretary or other principal officer of the Company.
In the event the person whose original or facsimile signature has been placed upon any Warrant shall have ceased to serve in the
capacity in which such person signed the Warrant before such Warrant is issued, it may be issued with the same effect as if he
or she had not ceased to be such at the date of issuance.

 

2.2 Effect of Countersignature.
Unless and until countersigned by the Warrant Agent pursuant to this Agreement, a Warrant shall be invalid and of no effect and
may not be exercised by the holder thereof.

 

2.3 Registration.

 

2.3.1 Warrant Register.
The Warrant Agent shall maintain books (the “Warrant Register”), for the registration of original issuance
and the registration of transfer of the Warrants. Except for fractional Warrants that are included in a Unit that has not been
separated into its constituent securities, no fractional Warrants may be transferred unless accompanied by other fractional Warrants
to be transferred that, in the aggregate allow for the purchase of one full placement share or an integral multiple thereof (collectively
“Whole Warrants” or individually a “Whole Warrant”). Upon the initial issuance of the Warrants, the Warrant
Agent shall issue and register the Warrants in the names of the respective holders thereof in such denominations and otherwise
in accordance with instructions delivered to the Warrant Agent by the Company.

 

2.3.2 Registered Holder.
Prior to due presentment for registration of transfer of any Whole Warrant, the Company and the Warrant Agent may deem and treat
the person in whose name such Whole Warrants are registered in the Warrant Register (the “Registered Holder”)
as the absolute owner of such Warrant and of each Warrant represented thereby (notwithstanding any notation of ownership or other
writing on the Warrant Certificate (as defined below) made by anyone other than the Company or the Warrant Agent), for the purpose
of any exercise thereof, and for all other purposes, and neither the Company nor the Warrant Agent shall be affected by any notice
to the contrary.

 

2.4 Detachability of Warrants.
The Common Stock and Public Warrants comprising the Public Units shall begin separate trading on the 52nd day following the date
of the Prospectus, or, if such 52nd day is not on a Business Day (as defined below), then on the immediately succeeding Business
Day following such date (the “Detachment Date”), unless Cantor, acting as representative of the Underwriters,
informs the Company of its decision to allow earlier separate trading, but in no event shall the Common Stock and the Public Warrants
comprising the Units be separately traded until (a) the Company has filed a Current Report on Form 8-K with the SEC that includes
an audited balance sheet reflecting its receipt of the gross proceeds of the Offering and (b) the Company issues a press release
announcing when such separate trading shall begin; provided, however, that, if the Over-allotment Option is exercised following
the filing of the initial Current Report on Form 8-K, a second or amended Current Report on Form 8-K shall be filed by the Company
to provide updated financial information to reflect the exercise of the Over-allotment Option. As used herein, “Business
Day” shall mean any day other than a Saturday, a Sunday or a legal holiday or a day on which banking institutions
or trust companies are authorized or obligated by law to close in New York City. Notwithstanding the foregoing, no fractional Warrants
will be issued upon the separation of the Units and any fractional Warrants resulting from the separation shall be terminated.

 

2.5 Warrant Attributes.

 

2.5.1 Placement Warrants.
The Placement Warrants shall be identical to the Public Warrants, except that so long as they are held by the Sponsor, Cantor,
or any of their respective Permitted Transferees (as defined below), the Placement Warrants: (a) may be exercised for cash
or on a cashless basis, pursuant to subsection 3.3.1(c) hereof, (b) shall not be redeemable by the Company and (c) may not
be transferred, assigned or sold until thirty (30) days after the completion by the Company of an initial Business Combination
(as defined below) except to a Permitted Transferee and the period during which the Placement Warrants held by Cantor are exercisable
may not be extended (pursuant to the last sentence of Section 3.2 or otherwise) beyond the date that is five years from the effective
date of the Registration Statement. A “Permitted Transferee” is hereby defined as any transferee receiving securities
in the following transactions:

 

(a) to Daniel G. Cohen,
Betsy Z. Cohen, DGC Family FinTech Trust, James J. McEntee, III, Swarthmore Trust of 2016, Shami Patel, Jeremy Kuiper or the Sponsor
(together, the “Initial Stockholders”), the Company’s officers, the Company’s directors,
or Cantor, or Cantor’s officers, directors or direct or indirect equityholders;

 

    	 	2	 

     

    

 

(b) to an affiliate or
immediate family member of any of the Company’s officers, directors, Initial Stockholders, and Cantor;

 

(c) to any member, officer
or director of the Sponsor, or any immediate family member, partner, affiliate or employee of a member of the Sponsor;

 

(d) by gift to any Permitted
Transferee under any of the immediately preceding subsections (a) through (c), to a trust, the beneficiaries of which consist entirely
of one or more Permitted Transferees under any of the immediately preceding subsections (a) through (d), or to a charitable organization;

 

(e) by virtue of laws of
descent and distribution upon the death of any officer or director of the Company, Initial Stockholder, member of the Sponsor,
or any officer, director or direct or indirect equityholders of Cantor;

 

(f) pursuant to a qualified
domestic relations order;

 

(g) upon the Company’s
liquidation prior to consummation of the Company’s initial business combination;

 

(h) by virtue of the laws
of Delaware, pursuant to the limited liability company agreement of the Sponsor upon dissolution of the Sponsor, or pursuant to
the organizational documents of Cantor upon dissolution of Cantor;

 

(i) upon and in connection
with the liquidation, merger, stock exchange or other similar transaction which results in all of the Company’s stockholders
having the right to exchange their shares of common stock for cash, securities or other property subsequent to the Company’s
consummation of its initial business combination; or

 

(j) subsequent to the consummation
of the Company’s initial business combination, in the event of a consolidation, merger, stock exchange or other similar transaction
in which the Company is the surviving entity that results in a change in a majority of the Company’s board of directors or
management team;

 

provided, however, that in the case of clauses
(a) through (f) and (h) these Permitted Transferees must enter into a written agreement agreeing to be bound by the restrictions
on transfer in this Agreement.

 

	 	3.	Terms and Exercise of Warrants.

 

3.1 Warrant Price.
Each Whole Warrant shall, when countersigned by the Warrant Agent, entitle the Registered Holder thereof, subject to the provisions
of such Warrant and of this Agreement, to purchase from the Company the number of shares of Common Stock stated therein, at the
price of $11.50 per share, subject to the adjustments provided in Section 4 hereof and in the last sentence of this Section 3.1.
The term “Warrant Price” as used in this Agreement shall mean the price per share at which a share of
Common Stock may be purchased pursuant to the Whole Warrant at the time such Whole Warrant is exercised. The Company in its sole
discretion may reduce the Warrant Price at any time prior to the Expiration Date (as defined below) for a period of not less than
twenty (20) Business Days, by providing at least twenty (20) days prior written notice of such reduction to each Registered
Holder. Any such reduction shall be identical among all of the Warrants.

 

    	 	3	 

     

    

 

3.2 Duration of Warrants.
A Whole Warrant may be exercised only during the period (the “Exercise Period”) commencing on the later
of: (a) thirty (30) days after the first date on which the Company consummates an acquisition, through a merger, capital stock
exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (a “Business
Combination”), or (b) 12 months from the date of the completion of the Offering (excluding any exercise of the
underwriters’ over-allotment option), and terminating at 5:00 p.m., New York City time, on the earlier of (x) five years
after the date on which the Company consummates its initial Business Combination, (y) the liquidation of the Company or, if
the Company fails to consummate a Business Combination, 24 months from the date of completion of the Offering (excluding any exercise
of the underwriters’ over-allotment option), or (z) with respect to all the Warrants except the Placement Warrants, the Redemption
Date (as defined below) (the “Expiration Date“); provided, however, that the exercise of any Warrant
shall be subject to the restrictions on exercise set forth in subsection 3.3.2 and 3.3.3. Each Warrant not exercised on or before
the Expiration Date shall become void, and all rights thereunder and all rights in respect thereof under this Agreement shall cease,
at 5:00 p.m. New York City time on the Expiration Date with the exception of rights of holders of Warrants (except for Placement
Warrants) to receive the Redemption Price (as defined below) upon a redemption in accordance with Section 6. The Company in its
sole discretion may extend the term of the Warrants by providing at least twenty (20) days prior written notice of any such
extension, including the new Expiration Date, to each Registered Holder. Any such extension shall be identical in duration among
all the Warrants.

 

3.3 Exercise of Warrants.

 

3.3.1 Payment. Subject
to the provisions of the Warrant and this Agreement, a Whole Warrant may be exercised by the Registered Holder thereof by surrendering
it at the office of the Warrant Agent in the Borough of Manhattan, City and State of New York, or at the office of its successor
as Warrant Agent, with the subscription form, as set forth in the Warrant, duly executed, and paying in full the Warrant Price
for each full share of Common Stock as to which the Whole Warrant is exercised and any and all applicable taxes due in connection
with the exercise of the Whole Warrant, the exchange of the Whole Warrant for the shares of Common Stock and the issuance of such
shares of Common Stock, as follows:

 

(a) by wire transfer
of immediately available funds in good certified check or good bank draft payable to the order of the Warrant Agent;

 

(b) upon a redemption
pursuant to Section 6 hereof in which the Company’s board of directors (the “Board”) has elected
to require all holders of the Warrants to exercise such Warrants on a “cashless basis,” by surrendering the Warrant
for that number of shares of Common Stock equal to the quotient obtained by dividing (x) the product of the number of shares
of Common Stock underlying the Warrant, multiplied by the difference between the Warrant Price and the “Fair Market Value”
(as defined in this subsection 3.3.1(b)) by (y) the Fair Market Value. Solely for purposes of this subsection 3.3.1(b) and
Section 6.3, “Fair Market Value” shall mean the average last sale price per share of the Common Stock for the
ten (10) trading day period ending on the third trading day prior to the date on which the notice of redemption is sent to
the holders of the Warrants;

 

(c) with respect to
any Placement Warrant exercised on a “cashless basis,” so long as such Placement Warrant is held by the Sponsor, Cantor,
or their Permitted Transferees, by surrendering the Warrants for that number of shares of Common Stock equal to the quotient obtained
by dividing (x) the product of the number of shares of Common Stock underlying the Warrants, multiplied by the difference
between the Warrant Price and the “Fair Market Value”, as defined in this subsection 3.3.1(c), by (y) the Fair
Market Value. Solely for purposes of this subsection 3.3.1(c), the “Fair Market Value” shall mean the average last
sale price of the Common Stock for the ten (10) trading day period ending on the third trading day prior to the date on which
notice of exercise of the Warrant is sent to the Warrant Agent; or

 

(d) as provided in
Section 7.4 hereof.

 

3.3.2 Exercise of Fractional
Warrants Not Permitted. No fractional Warrant shall be exercisable or redeemable in any manner unless accompanied by other
fractional Warrants to be exercised or redeemed that, in the aggregate for all such fractional Warrants, constitute a Whole Warrant
or Whole Warrants. 

 

    	 	4	 

     

    

 

3.3.3 Issuance of Shares
of Common Stock on Exercise. As soon as practicable after the exercise of any Whole Warrant and the clearance of the funds
in payment of the Warrant Price (if payment is pursuant to subsection 3.3.1(a)), the Company shall issue to the Registered Holder
of such Whole Warrant a certificate or certificates for the number of full shares of Common Stock to which he, she or it is entitled,
registered in such name or names as may be directed by him, her or it, and if such Whole Warrant shall not have been exercised
in full, a new countersigned Warrant for the number of shares as to which such Warrant shall not have been exercised. Subject to
and except as set forth in Section 7.4, no Warrant shall be exercisable and the Company shall not be obligated to settle a Warrant
exercise or issue Common Stock upon exercise of a Warrant unless a registration statement under the Securities Act with respect
to the Common Stock underlying the Public Warrants is then effective and a prospectus relating thereto is current and the Common
Stock issuable upon such Warrant exercise has been registered, qualified or deemed to be exempt under the securities laws of the
state of residence of the Registered Holder of the Warrants. The Company shall not be required to net cash settle the Warrant exercise.

 

3.3.4 Valid Issuance.
All Common Stock issued upon the proper exercise of a Warrant in conformity with this Agreement shall be validly issued, fully
paid and nonassessable.

 

3.3.5 Date of Issuance.
Each person in whose name any certificate for Common Stock is issued shall for all purposes be deemed to have become the holder
of record of such Common Stock on the date on which the Whole Warrant was surrendered and payment of the Warrant Price was made,
irrespective of the date of delivery of such certificate, except that, if the date of such surrender and payment is a date when
the share transfer books of the Company are closed, such person shall be deemed to have become the holder of such shares at the
close of business on the next succeeding date on which the share transfer books are open.

 

3.3.6 Maximum Percentage.
A holder of a Warrant may notify the Company in writing if it elects to be subject to the provisions contained in this subsection
3.3.6; provided, however, that no holder of a Warrant shall be subject to this subsection 3.3.6 unless he, she or it makes such
election. If the election is made by a holder, the Warrant Agent shall not effect the exercise of the holder’s Warrant, and
such holder shall not have the right to exercise such Warrant, to the extent that after giving effect to such exercise, such person
(together with such person’s affiliates), to the Warrant Agent’s actual knowledge, would beneficially own in excess
of 9.8% (the “Maximum Percentage”) of the Common Stock outstanding immediately after giving effect to
such exercise. For purposes of the foregoing sentence, the aggregate number of shares of Common Stock beneficially owned by such
person and its affiliates shall include the number of shares of Common Stock issuable upon exercise of the Warrant with respect
to which the determination of such sentence is being made, but shall exclude Common Stock that would be issuable upon (x) exercise
of the remaining, unexercised portion of the Warrant beneficially owned by such person and its affiliates and (y) exercise
or conversion of the unexercised or unconverted portion of any other securities of the Company beneficially owned by such person
and its affiliates (including, without limitation, any convertible notes or convertible preferred stock or warrants) subject to
a limitation on conversion or exercise analogous to the limitation contained herein. Except as set forth in the preceding sentence,
for purposes of this paragraph, beneficial ownership shall be calculated in accordance with Section 13(d) of the Securities Exchange
Act of 1934, as amended (the “Exchange Act”). For purposes of the Warrant, in determining the number
of outstanding shares of Common Stock, the holder may rely on the number of outstanding shares of Common Stock as reflected in
(1) the Company’s most recent annual report on Form 10-K, quarterly report on Form 10-Q, current report on Form 8-K or other
public filing with the Commission as the case may be, (2) a more recent public announcement by the Company, or (3) any other
notice by the Company or the Transfer Agent setting forth the number of shares of Common Stock outstanding. For any reason at any
time, upon the written request of the holder of the Warrant, the Company shall, within two (2) Business Days, confirm orally
and in writing to such holder the number of shares of Common Stock then outstanding. In any case, the number of outstanding shares
of Common Stock shall be determined after giving effect to the conversion or exercise of equity securities of the Company by the
holder and its affiliates since the date as of which such number of outstanding shares of Common Stock was reported. By written
notice to the Company, the holder of a Warrant may from time to time increase or decrease the Maximum Percentage applicable to
such holder to any other percentage specified in such notice; provided, however, that any such increase shall not be effective
until the sixty-first (61st) day after such notice is delivered to the Company.

 

    	 	5	 

     

    

 

	 	4.	Adjustments.

 

4.1 Stock Dividends.

 

4.1.1 Split-Ups.
If after the date hereof, and subject to the provisions of Section 4.6 below, the number of outstanding shares of Common Stock
is increased by a stock dividend payable in Common Stock, or by a split-up of the Common Stock or other similar event, then, on
the effective date of such stock dividend, split-up or similar event, the number of shares of Common Stock issuable on exercise
of each Warrant shall be increased in proportion to such increase in the outstanding shares of Common Stock. A rights offering
to holders of the Common Stock entitling holders to purchase Common Stock at a price less than the “Fair Market Value”
(as defined below) shall be deemed a stock dividend of a number of shares of Common Stock equal to the product of (i) the
number of shares of Common Stock actually sold in such rights offering (or issuable under any other equity securities sold in such
rights offering that are convertible into or exercisable for the Common Stock) multiplied by (ii) one (1) minus the quotient
of (x) the price per share of Common Stock paid in such rights offering divided by (y) the Fair Market Value. For purposes
of this subsection 4.1.1, (i) if the rights offering is for securities convertible into or exercisable for Common Stock, in
the determination of the price payable for Common Stock shall take into account any consideration received for such rights, as
well as any additional amount payable upon exercise or conversion and (ii) “Fair Market Value” means, for purposes
of this subsection 4.1.1 only, the volume weighted average price of the Common Stock as reported during the ten (10) trading
day period ending on the trading day prior to the first date on which the Common Stock trades on the applicable exchange or in
the applicable market, regular way, without the right to receive such rights.

 

4.1.2 Extraordinary
Dividends. If at any time while the Warrants are outstanding and unexpired, the Company shall pay a dividend or make a distribution
in cash, securities or other assets to the holders of the Common Stock on account of such Common Stock (or other shares of the
Company’s capital stock into which the Warrants are convertible), other than (a) as described in subsection 4.1.1 above,
(b) Ordinary Cash Dividends (as defined below), (c) to satisfy the redemption rights of the holders of the Common Stock
in connection with a proposed initial Business Combination, (d) as a result of the repurchase of Common Stock by the Company
if a proposed initial Business Combination is presented to the stockholders of the Company for approval or (e) in connection
with the Company’s liquidation and the distribution of its assets upon its failure to consummate a Business Combination (any
such non-excluded event being referred to herein as an (“Extraordinary Dividend”), then the Warrant Price
shall be decreased, effective immediately after the effective date of such Extraordinary Dividend, by the amount of cash and/or
the fair market value (as determined by the Board, in good faith) of any securities or other assets paid on each share of Common
Stock in respect of such Extraordinary Dividend. For purposes of this subsection 4.1.2, “Ordinary Cash Dividends”
means any cash dividend or cash distribution which, when combined on a per share basis, with the per share amounts of all other
cash dividends and cash distributions paid on the Common Stock during the 365-day period ending on the date of declaration of such
dividend or distribution (as adjusted to appropriately reflect any of the events referred to in other subsections of this Section 4
and excluding cash dividends or cash distributions that resulted in an adjustment to the Warrant Price or to the number of shares
of Common Stock issuable on exercise of each Warrant) does not exceed $0.50 (being 5% of the offering price of the Units in the
Offering).

 

4.2 Aggregation of Shares.
If at any time while the Warrants are outstanding and unexpired, , subject to the provisions of Section 4.6 hereof, the number
of outstanding shares of Common Stock is decreased by a consolidation, combination, reverse stock split or reclassification of
Common Stock or other similar event, then, on the effective date of such consolidation, combination, reverse stock split, reclassification
or similar event, the number of shares of Common Stock issuable on exercise of each Warrant shall be decreased in proportion to
such decrease in outstanding shares of Common Stock.

 

4.3 Adjustments in Exercise
Price. Whenever the number of shares of Common Stock issuable upon the exercise of the Warrants is adjusted, as provided in
subsection 4.1.1 or 4.2 above, the Warrant Price shall be adjusted (to the nearest cent) by multiplying such Warrant Price immediately
prior to such adjustment by a fraction (x) the numerator of which shall be the number of shares of Common Stock issuable upon
the exercise of the Warrants immediately prior to such adjustment, and (y) the denominator of which shall be the number of
shares of Common Stock so issuable immediately thereafter.

 

    	 	6	 

     

    

 

4.4 Replacement of Securities
upon Reorganization, etc. In the event of (a) any reclassification or reorganization of the outstanding Common Stock (other
than a change under subsections 4.1.1 or 4.1.2 or Section 4.2 hereof or that solely affects the par value of the Common Stock),
(b) any merger or consolidation of the Company with or into another corporation (other than a consolidation or merger in which
the Company is the continuing corporation and that does not result in any reclassification or reorganization of the outstanding
Common Stock) or (c) the sale or conveyance of all or substantially all of the Company’s assets in one transaction or a series
of related transactions, the holders of Whole Warrants shall thereafter have the right to purchase and receive, upon the basis
and upon the terms and conditions specified in the Warrants and in lieu of the Common Stock of the Company immediately theretofore
purchasable and receivable upon the exercise of the rights represented thereby, the kind and amount of shares of stock or other
securities or property (including cash) receivable upon such reclassification, reorganization, merger or consolidation, or upon
a dissolution following any such sale or transfer, that the holder of the Warrants would have received if such holder had exercised
his, her or its Whole Warrant(s) immediately prior to such event (the “Alternative Issuance”); provided,
however, that (i) if the holders of the Common Stock were entitled to exercise a right of election as to the kind or amount
of securities, cash or other assets receivable upon such consolidation or merger, then the kind and amount of securities, cash
or other assets constituting the Alternative Issuance for which each Whole Warrant shall become exercisable shall be deemed to
be the weighted average of the kind and amount received per share by the holders of the Common Stock in such consolidation or merger
that affirmatively make such election, and (ii) if a tender, exchange or redemption offer shall have been made to, and accepted
by, the holders of the Common Stock (other than a tender, exchange or redemption offer made by the Company in connection with redemption
rights held by stockholders of the Company as provided for in the Company’s amended and restated certificate of incorporation
or as a result of the repurchase of Common Stock by the Company if a proposed initial Business Combination is presented to the
stockholders of the Company for approval) under circumstances in which, upon completion of such tender or exchange offer, the maker
thereof, together with members of any group (within the meaning of Rule 13d-5(b)(1) under the Exchange Act) of which such
maker is a part, and together with any affiliate or associate of such maker (within the meaning of Rule 12b-2 under the Exchange
Act) and any members of any such group of which any such affiliate or associate is a part, own beneficially (within the meaning
of Rule 13d-3 under the Exchange Act) more than 50% of the outstanding Common Stock, the holder of a Warrant shall be entitled
to receive as the Alternative Issuance, the highest amount of cash, securities or other property to which such holder would actually
have been entitled as a stockholder if such Warrant holder had exercised the Warrant prior to the expiration of such tender or
exchange offer, accepted such offer and all of the Common Stock held by such holder had been purchased pursuant to such tender
or exchange offer, subject to adjustments (from and after the consummation of such tender or exchange offer) as nearly equivalent
as possible to the adjustments provided for in this Section 4; provided further, however, that if less than 70% of the consideration
receivable by the holders of the Common Stock in the applicable event is payable in the form of common stock in the successor entity
that is listed for trading on a national securities exchange or is quoted in an established over-the-counter market, or is to be
so listed for trading or quoted immediately following such event, and if the Registered Holder properly exercises the Warrant within
thirty (30) days following the public disclosure of the consummation of such applicable event by the Company pursuant to a Current
Report on Form 8-K filed with the SEC, the Warrant Price shall be reduced by an amount (in dollars) equal to the difference of
(i) the Warrant Price in effect prior to such reduction minus (ii) (A) the Per Share Consideration (as defined below) (but in no
event less than zero) minus (B) the Black-Scholes Warrant Value (as defined below). The “Black-Scholes Warrant Value”
means the value of a Warrant immediately prior to the consummation of the applicable event based on the Black-Scholes Warrant Model
for a Capped American Call on Bloomberg Financial Markets (“Bloomberg”). For purposes of calculating
such amount, (1) Section 6 of this Agreement shall be taken into account, (2) the price of each share of Common Stock
shall be the volume weighted average price of the Common Stock as reported during the ten (10) trading day period ending on the
trading day prior to the effective date of the applicable event, (3) the assumed volatility shall be the 90 day volatility obtained
from the HVT function on Bloomberg determined as of the trading day immediately prior to the day of the announcement of the applicable
event, and (4) the assumed risk-free interest rate shall correspond to the U.S. Treasury rate for a period equal to the remaining
term of the Warrant. “Per Share Consideration” means (i) if the consideration paid to holders of
the Common Stock consists exclusively of cash, the amount of such cash per share of Common Stock, and (ii) in all other cases,
the volume weighted average price of the Common Stock as reported during the ten (10) trading day period ending on the trading
day prior to the effective date of the applicable event. If any reclassification or reorganization also results in a change in
shares of Common Stock covered by subsection 4.1.1, then such adjustment shall be made pursuant to subsection 4.1.1 or Sections
4.2, 4.3 and this Section 4.4. The provisions of this Section 4.4 shall similarly apply to successive
reclassifications, reorganizations, mergers or consolidations, sales or other transfers.

 

    	 	7	 

     

    

 

4.5 Notices of Changes
in Warrant. Upon every adjustment of the Warrant Price or the number of shares issuable upon exercise of a Warrant, the Company
shall give written notice thereof to the Warrant Agent, which notice shall state the Warrant Price resulting from such adjustment
and the increase or decrease, if any, in the number of shares purchasable at such price upon the exercise of a Warrant, setting
forth in reasonable detail the method of calculation and the facts upon which such calculation is based. Upon the occurrence of
any event specified in Sections 4.1, 4.2, 4.3 or 4.4, the Company shall give written notice of the occurrence of such event to
each holder of a Warrant, at the last address set forth for such holder in the Warrant Register, of the record date or the effective
date of the event. Failure to give such notice, or any defect therein, shall not affect the legality or validity of such event.

 

4.6 No Fractional Shares.
Notwithstanding any provision contained in this Agreement to the contrary, the Company shall not issue fractional shares upon exercise
of Warrants. If, by reason of any adjustment made pursuant to this Section 4, the holder of any Warrant would be entitled,
upon the exercise of such Warrant, to receive a fractional interest in a share, the Company shall, upon such exercise, round down
to the nearest whole number, the number of the shares of Common Stock to be issued to such holder.

 

4.7 Form of Warrant.
The form of Warrant need not be changed because of any adjustment pursuant to this Section 4, and Warrants issued after such
adjustment may state the same Warrant Price and the same number of shares as is stated in the Warrants initially issued pursuant
to this Agreement; provided, however, that the Company may at any time in its sole discretion make any change in the form of Warrant
that the Company may deem appropriate and that does not affect the substance thereof, and any Warrant thereafter issued or countersigned,
whether in exchange or substitution for an outstanding Warrant or otherwise, may be in the form as so changed.

 

4.8 Other Events.
In case any event shall occur affecting the Company as to which none of the provisions of preceding subsections of this Section 4
are strictly applicable, but which would require an adjustment to the terms of the Warrants in order to (i) avoid an adverse
impact on the Warrants and (ii) effectuate the intent and purpose of this Section 4, then, in each such case, the Company
shall appoint a firm of independent public accountants, or an investment banking or other appraisal firm of recognized national
standing, which shall give its opinion as to whether or not any adjustment to the rights represented by the Warrants is necessary
to effectuate the intent and purpose of this Section 4 and, if they determine that an adjustment is necessary, the terms of
such adjustment; provided, however, that the Warrants shall not be adjusted pursuant to this Section 4 as a result of any issuance
of securities in connection with an initial Business Combination. The Company shall adjust the terms of the Warrants in a manner
that is consistent with any adjustment recommended in such opinion.

 

	 	5.	Transfer and Exchange of Warrants.

 

5.1 Registration of Transfer.
Subject to subsection 2.3.1, the Warrant Agent shall register the transfer, from time to time, of any outstanding Whole Warrant
upon the Warrant Register, upon surrender of such Warrant for transfer, properly endorsed with signatures properly guaranteed and
accompanied by appropriate instructions for transfer. Upon any such transfer, a new Warrant representing an equal aggregate number
of Whole Warrants shall be issued and the old Warrant shall be cancelled by the Warrant Agent. The Warrants so cancelled shall
be delivered by the Warrant Agent to the Company from time to time upon request.

 

5.2 Procedure for Surrender
of Warrants. Whole Warrants may be surrendered to the Warrant Agent, together with a written request for exchange or transfer,
and thereupon the Warrant Agent shall issue in exchange therefor one or more new Warrants as requested by the Registered Holder
of the Warrants so surrendered, representing an equal aggregate number of Warrants; provided, however, that, if a Warrant surrendered
for transfer bears a restrictive legend (as in the case of the Placement Warrants), the Warrant Agent shall not cancel such Warrant
and issue new Warrants in exchange thereof until the Warrant Agent has received an opinion of counsel for the Company stating that
such transfer may be made and indicating whether the new Warrants must also bear a restrictive legend.

 

5.3 Fractional Warrants.
The Warrant Agent shall not be required to effect any registration of transfer or exchange which shall result in the issuance of
a warrant certificate for a fraction of a warrant.

 

    	 	8	 

     

    

 

5.4 Service Charges.
No service charge shall be made for any exchange or registration of transfer of Warrants.

 

5.5 Warrant Execution
and Countersignature. The Warrant Agent is hereby authorized to countersign and to deliver, in accordance with the terms of
this Agreement, the Warrants required to be issued pursuant to the provisions of this Section 5, and the Company, whenever
required by the Warrant Agent, shall supply the Warrant Agent with Warrants duly executed on behalf of the Company for such purpose.

 

5.6 Transfer of Warrants.
Prior to the Detachment Date, the Public Warrants may be transferred or exchanged only together with the Units in which such Warrant
is included, and only for the purpose of effecting, or in conjunction with, a transfer or exchange of such Unit. Furthermore, each
transfer of a Unit on the register relating to such Units shall operate also to transfer the fractional Warrants included in such
Unit.

 

	 	6.	Redemption.

 

6.1 Redemption. Subject
to Section 6.4 hereof, not less than all of the outstanding Warrants may be redeemed at the option of the Company, at any
time while they are exercisable and prior to their expiration, at the office of the Warrant Agent, upon notice to the Registered
Holders of the Warrants, as described in Section 6.2 below, at a price of $0.01 per Warrant (the “Redemption Price”);
provided, that the last sales price of the Common Stock (or the closing bid price of the Common Stock if shares of the Common Stock
are not traded on any specific trading day) reported has been at least $24.00 per share (subject to adjustment in compliance with
Section 4 hereof), on each of twenty (20) trading days within the thirty (30) trading-day period ending on the third
Business Day prior to the date on which notice of the redemption is given; and, provided further that there is an effective registration
statement covering the Common Stock issuable upon exercise of the Warrants, and a current prospectus relating thereto, available
throughout the 30-day Redemption Period (as defined in Section 6.2 below) or the Company has elected to require the exercise
of the Warrants on a “cashless basis” pursuant to subsection 3.3.1.; and provided further that, after aggregating all
of the fractional Warrants held by a Registered Holder, there remains a fractional Warrant held by such Registered Holder, such
fractional Warrant shall not be redeemed and will terminate on the Redemption Date (as defined in Section 6.2).

 

6.2 Date Fixed for, and
Notice of, Redemption. If the Company elects to redeem the Warrants in accordance with Section 6.1, the Company shall fix a
date for the redemption (the “Redemption Date”). Notice of redemption shall be mailed by first class
mail, postage prepaid, by the Company not less than thirty (30) days prior to the Redemption Date (such 30-day period, the
“Redemption Period”) to the Registered Holders of the Warrants to be redeemed at their last addresses
as they shall appear on the registration books. Any notice mailed in the manner herein provided shall be conclusively presumed
to have been duly given whether or not the Registered Holder received such notice.

 

6.3 Exercises After Notice
of Redemption. The Warrants may be exercised for cash (or on a “cashless basis” in accordance with subsection 3.3.1(b))
at any time after notice of redemption shall have been given by the Company pursuant to Section 6.2 hereof and prior to the
Redemption Date. If the Company determines to require all holders of Warrants to exercise their Warrants on a “cashless basis”
pursuant to subsection 3.3.1, the notice of redemption shall contain the information necessary to calculate the number of shares
of Common Stock to be received upon exercise of the Warrants, including the “Fair Market Value” (as such term is defined
in subsection 3.3.1(b)) in such case. On and after the Redemption Date, the record holder of the Warrants shall have no further
rights except to receive, upon surrender of the Warrants, the Redemption Price.

 

6.4 Exclusion of Placement
Warrants. The Company agrees that the redemption rights provided in this Section 6 shall not apply to the Placement Warrants
if at the time of the redemption such Placement Warrants continue to be held by the Sponsor, Cantor, or their Permitted Transferees;
provided, however, that once such Placement Warrants are transferred (other than to Permitted Transferees under subsection 2.5),
the Company may redeem the Placement Warrants, provided that the criteria for redemption are met, including the opportunity of
the holder of such Placement Warrants to exercise the Placement Warrants prior to redemption pursuant to Section 6.3. Placement
Warrants that are transferred to persons other than Permitted Transferees shall, upon such transfer, cease to be Placement Warrants
and shall become Public Warrants under this Agreement.

 

    	 	9	 

     

    

 

	 	7.	Other Provisions Relating to Rights of Holders of Warrants.

 

7.1 No Rights as Stockholder.
A Warrant does not entitle the Registered Holder thereof to any of the rights of a stockholder of the Company, including, without
limitation, the right to receive dividends or other distributions, exercise any preemptive rights to vote or to consent or to receive
notice as stockholders in respect of the meetings of stockholders or the election of directors of the Company or any other matter.

 

7.2 Lost, Stolen, Mutilated,
or Destroyed Warrants. If any Warrant is lost, stolen, mutilated, or destroyed, the Company and the Warrant Agent may on such
terms as to indemnity or otherwise as they may in their discretion impose (which shall, in the case of a mutilated Warrant, include
the surrender thereof), issue a new Warrant of like denomination, tenor, and date as the Warrant so lost, stolen, mutilated, or
destroyed. Any such new Warrant shall constitute a substitute contractual obligation of the Company, whether or not the allegedly
lost, stolen, mutilated, or destroyed Warrant shall be at any time enforceable by anyone.

 

7.3 Reservation of Common
Stock. The Company shall at all times reserve and keep available a number of shares of its authorized but unissued Common Stock
that shall be sufficient to permit the exercise in full of all outstanding Warrants issued pursuant to this Agreement.

 

7.4 Registration of Common
Stock; Cashless Exercise at Company’s Option.

 

7.4.1 Registration of
Common Stock. The Company agrees that as soon as practicable, but in no event later than twenty (20) Business Days after
the closing of its initial Business Combination, it shall use its best efforts to file with the Commission a post-effective amendment
to the Registration Statement, or a new registration statement, for the registration, under the Securities Act, of the Common Stock
issuable upon exercise of the Warrants, and it shall use its best efforts to take such action as is necessary to register or qualify
for sale, in those states in which the Warrants were initially offered by the Company, the Common Stock issuable upon exercise
of the Warrants, to the extent an exemption is not available. The Company shall use its best efforts to cause the same to become
effective and to maintain the effectiveness of such registration statement, and a current prospectus relating thereto, until the
expiration of the Warrants in accordance with the provisions of this Agreement. If any such post-effective amendment or registration
statement has not been declared effective by the sixtieth (60th) Business Day following the closing of the Business Combination,
holders of the Warrants shall have the right, during the period beginning on the sixty-first (61st) Business Day after the closing
of the Business Combination and ending upon such post-effective amendment or registration statement being declared effective by
the Commission, and during any other period when the Company shall fail to have maintained an effective registration statement
covering the Common Stock issuable upon exercise of the Warrants, to exercise Whole Warrants on a “cashless basis,”
by exchanging Whole Warrants (in accordance with Section 3(a)(9) of the Securities Act or another exemption) for that number
of shares of Common Stock equal to the quotient obtained by dividing (x) the product of the number of shares of Common Stock
underlying the Whole Warrants, multiplied by the difference between the Warrant Price and the “Fair Market Value” (as
defined below) by (y) the Fair Market Value. Solely for purposes of this Section 7.4, “Fair Market Value”
shall mean the volume weighted average price of the Common Stock as reported during the ten (10) trading day period ending
on the trading day prior to the date that notice of exercise is received by the Warrant Agent from the holder of such Whole Warrants
or its securities broker or intermediary. The date that notice of cashless exercise is received by the Warrant Agent shall be conclusively
determined by the Warrant Agent. In connection with the “cashless exercise” of a Public Warrant, the Company shall,
upon request, provide the Warrant Agent with an opinion of counsel for the Company (which shall be an outside law firm with securities
law experience) stating that (i) the exercise of Whole Warrants on a cashless basis in accordance with this Section 7.4
is not required to be registered under the Securities Act and (ii) the Common Stock issued upon such exercise shall be freely
tradable under United States federal securities laws by anyone who is not an affiliate (as such term is defined in Rule 144
under the Securities Act) of the Company and, accordingly, shall not be required to bear a restrictive legend. For the avoidance
of any doubt, unless and until all Whole Warrants have been exercised, the Company shall continue to be obligated to comply with
its registration obligations under the first three sentences of this Section 7.4.1.

 

    	 	10	 

     

    

 

7.4.2 Cashless Exercise
at Company’s Option. If the Common Stock is at the time of any exercise of a Whole Warrant not listed on a national securities
exchange such that it satisfies the definition of a “covered security” under Section 18(b)(1) of the Securities Act,
the Company may, at its option, (i) require holders of Public Warrants who exercise Public Warrants (which, for the avoidance of
doubt may only be Whole Warrants) to exercise such Public Warrants on a “cashless basis” in accordance with Section
3(a)(9) of the Securities Act as described in subsection 7.4.1 and (ii) in the event the Company so elects, the Company shall not
be required to file or maintain in effect a registration statement for the registration, under the Securities Act, of the Common
Stock issuable upon exercise of the Warrants, notwithstanding anything in this Agreement to the contrary. If the Company does not
elect at the time of exercise to require a holder of Public Warrants who exercises Public Warrants to exercise such Public Warrants
on a “cashless basis,” it agrees to use its best efforts to register or qualify for sale the Common Stock issuable
upon exercise of the Public Warrant under the blue sky laws of the state of residence (in those states in which the Warrants were
initially offered by the Company) of the exercising Public Warrant holder to the extent an exemption is not available

 

	 	8.	Concerning the Warrant Agent and Other Matters.

 

8.1 Payment of Taxes.
The Company shall from time to time promptly pay all taxes and charges that may be imposed upon the Company or the Warrant Agent
in respect of the issuance or delivery of Common Stock upon the exercise of the Warrants, but the Company shall not be obligated
to pay any transfer taxes in respect of the Warrants or such shares.

 

8.2 Resignation, Consolidation,
or Merger of Warrant Agent.

 

8.2.1 Appointment of
Successor Warrant Agent. The Warrant Agent, or any successor to it hereafter appointed, may resign its duties and be discharged
from all further duties and liabilities hereunder after giving sixty (60) days’ notice in writing to the Company. If
the office of the Warrant Agent becomes vacant by resignation or incapacity to act or otherwise, the Company shall appoint in writing
a successor Warrant Agent in place of the Warrant Agent. If the Company shall fail to make such appointment within a period of
thirty (30) days after it has been notified in writing of such resignation or incapacity by the Warrant Agent or by the holder
of a Warrant (who shall, with such notice, submit his Warrant for inspection by the Company), then the holder of any Warrant may
apply to the Supreme Court of the State of New York for the County of New York for the appointment of a successor Warrant Agent
at the Company’s cost. Any successor Warrant Agent, whether appointed by the Company or by such court, shall be a corporation
organized and existing under the laws of the State of New York, in good standing and having its principal office in the Borough
of Manhattan, City and State of New York, and authorized under such laws to exercise corporate trust powers and subject to supervision
or examination by federal or state authority. After appointment, any successor Warrant Agent shall be vested with all the authority,
powers, rights, immunities, duties, and obligations of its predecessor Warrant Agent with like effect as if originally named as
Warrant Agent hereunder, without any further act or deed; but if for any reason it becomes necessary or appropriate, the predecessor
Warrant Agent shall execute and deliver, at the expense of the Company, an instrument transferring to such successor Warrant Agent
all the authority, powers, and rights of such predecessor Warrant Agent hereunder; and upon request of any successor Warrant Agent
the Company shall make, execute, acknowledge, and deliver any and all instruments in writing for more fully and effectually vesting
in and confirming to such successor Warrant Agent all such authority, powers, rights, immunities, duties, and obligations.

 

8.2.2 Notice of Successor
Warrant Agent. In the event a successor Warrant Agent shall be appointed, the Company shall give notice thereof to the predecessor
Warrant Agent and the Transfer Agent for the Common Stock not later than the effective date of any such appointment.

 

8.2.3 Merger or Consolidation
of Warrant Agent. Any corporation into which the Warrant Agent may be merged or with which it may be consolidated or any corporation
resulting from any merger or consolidation to which the Warrant Agent shall be a party shall be the successor Warrant Agent under
this Agreement without any further act.

 

    	 	11	 

     

    

 

8.3 Fees and Expenses
of Warrant Agent.

 

8.3.1 Remuneration.
The Company agrees to pay the Warrant Agent reasonable remuneration for its services as such Warrant Agent hereunder and shall,
pursuant to its obligations under this Agreement, reimburse the Warrant Agent upon demand for all expenditures that the Warrant
Agent may reasonably incur in the execution of its duties hereunder.

 

8.3.2 Further Assurances.
The Company agrees to perform, execute, acknowledge, and deliver or cause to be performed, executed, acknowledged, and delivered
all such further and other acts, instruments, and assurances as may reasonably be required by the Warrant Agent for the carrying
out or performing of the provisions of this Agreement.

 

8.4 Liability of Warrant
Agent.

 

8.4.1 Reliance on Company
Statement. Whenever in the performance of its duties under this Agreement, the Warrant Agent shall deem it necessary or desirable
that any fact or matter be proved or established by the Company prior to taking or suffering any action hereunder, such fact or
matter (unless other evidence in respect thereof be herein specifically prescribed) may be deemed to be conclusively proved and
established by a statement signed by the President, Chief Executive Officer or Chairman of the Board of the Company and delivered
to the Warrant Agent. The Warrant Agent may rely upon such statement for any action taken or suffered in good faith by it pursuant
to the provisions of this Agreement.

 

8.4.2 Indemnity. The
Warrant Agent shall be liable hereunder only for its own gross negligence, willful misconduct or bad faith. The Company agrees
to indemnify the Warrant Agent and save it harmless against any and all liabilities, including judgments, costs and reasonable
counsel fees, for anything done or omitted by the Warrant Agent in the execution of this Agreement, except as a result of the Warrant
Agent’s gross negligence, willful misconduct or bad faith.

 

8.4.3 Exclusions.
The Warrant Agent shall have no responsibility with respect to the validity of this Agreement or with respect to the validity or
execution of any Warrant (except its countersignature thereof). The Warrant Agent shall not be responsible for any breach by the
Company of any covenant or condition contained in this Agreement or in any Warrant. The Warrant Agent shall not be responsible
to make any adjustments required under the provisions of Section 4 hereof or responsible for the manner, method, or amount
of any such adjustment or the ascertaining of the existence of facts that would require any such adjustment; nor shall it by any
act hereunder be deemed to make any representation or warranty as to the authorization or reservation of any Common Stock to be
issued pursuant to this Agreement or any Warrant or as to whether any Common Stock shall, when issued, be valid and fully paid
and nonassessable.

 

8.5 Acceptance of Agency. The Warrant
Agent hereby accepts the agency established by this Agreement and agrees to perform the same upon the terms and conditions herein
set forth and among other things, shall account promptly to the Company with respect to Warrants exercised and concurrently account
for, and pay to the Company, all monies received by the Warrant Agent for the purchase of the Common Stock through the exercise
of the Warrants.

 

8.6 Waiver. The Warrant Agent has no
right of set-off or any other right, title, interest or claim of any kind (“Claim”) in, or to any distribution
of, the Trust Account (as defined in that certain Investment Management Trust Agreement, dated as of the date hereof, by and between
the Company and the Warrant Agent as trustee thereunder) and hereby agrees not to seek recourse, reimbursement, payment or satisfaction
for any Claim against the Trust Account for any reason whatsoever. The Warrant Agent hereby waives any and all Claims against the
Trust Account and any and all rights to seek access to the Trust Account.

 

9. Miscellaneous Provisions.

 

9.1 Successors.
All the covenants and provisions of this Agreement by or for the benefit of the Company or the Warrant Agent shall bind and inure
to the benefit of their respective successors and assigns.

 

    	 	12	 

     

    

 

9.2 Notices. Any
notice, statement or demand authorized by this Agreement shall be sufficiently given (i) when so delivered if by hand or overnight
delivery, (ii) upon receipt of by the intended recipient if by facsimile, or (ii) if sent by certified mail or private courier
service within five (5) days after deposit of such notice, postage prepaid, addressed (until another address is filed in writing
with the Warrant Agent) as follows:

 

If to the Company:

 

FinTech Acquisition Corp. II

2929 Arch Street, Suite 1703

Philadelphia, PA 19104-2870

Attention: James J. McEntee, President and Chief Financial
Officer

 

If to the Warrant Agent:

 

Continental Stock Transfer & Trust Company

17 Battery Place

New York, New York 10004

Fax: 212-616-7615

Attention: Compliance Department

 

with a copy in each case (which shall not constitute
service) to:

 

Ledgewood

2001 Market Street, Suite 3400

Philadelphia PA 19103

Fax: 215-735-2513

Attention: Amanda J. Abrams, Esq.

 

9.3 Applicable Law.
The validity, interpretation, and performance of this Agreement and of the Warrants shall be governed in all respects by the laws
of the State of New York and without giving effect to conflicts of law principles that would result in the application of the substantive
laws of another jurisdiction. The Company hereby agrees that any action, proceeding or claim against it arising out of or relating
in any way to this Agreement shall be brought and enforced in the courts of the State of New York or the United States District
Court for the Southern District of New York, and irrevocably submits to such jurisdiction, which jurisdiction shall be exclusive.
The Company hereby waives any objection to such exclusive jurisdiction and that such courts represent an inconvenient forum.

 

9.4 Persons Having Rights
under this Agreement. Nothing in this Agreement shall be construed to confer upon, or give to, any person or corporation other
than the parties hereto and the Registered Holders of the Warrants any right, remedy, or claim under or by reason of this Agreement
or of any covenant, condition, stipulation, promise, or agreement hereof. All covenants, conditions, stipulations, promises, and
agreements contained in this Agreement shall be for the sole and exclusive benefit of the parties hereto and their successors and
assigns and of the Registered Holders of the Warrants.

 

9.5 Examination of the
Agreement. A copy of this Agreement shall be available at all reasonable times at the office of the Warrant Agent in the Borough
of Manhattan, City and State of New York, for inspection by the Registered Holder of any Warrant. The Warrant Agent may require
any such holder to submit his Warrant for inspection by it.

 

9.6 Counterparts.
This Agreement may be executed in any number of original or facsimile counterparts and each of such counterparts shall for all
purposes be deemed to be an original, and all such counterparts shall together constitute but one and the same instrument.

 

9.7 Effect of Headings.
The section headings herein are for convenience only and are not part of this Agreement and shall not affect the interpretation
thereof.

 

    	 	13	 

     

    

 

9.8 Amendments. This
Agreement may be amended by the parties hereto without the consent of any Registered Holder for the purpose of curing any ambiguity,
or curing, correcting or supplementing any defective provision contained herein or adding or changing any other provisions with
respect to matters or questions arising under this Agreement as the parties may deem necessary or desirable and that the parties
deem shall not adversely affect the interest of the Registered Holders. All other modifications or amendments, including any amendment
to increase the Warrant Price or shorten the Exercise Period and any amendment to the terms of only the Placement Warrants, shall
require the vote or written consent of the Registered Holders of 65% of the then outstanding Warrants. Notwithstanding the foregoing,
the Company may lower the Warrant Price or extend the duration of the Exercise Period pursuant to Sections 3.1 and 3.2, respectively,
without the consent of the Registered Holders.

 

9.9 Severability.
This Agreement shall be deemed severable, and the invalidity or unenforceability of any term or provision hereof shall not affect
the validity or enforceability of this Agreement or of any other term or provision hereof. Furthermore, in lieu of any such invalid
or unenforceable term or provision, the parties hereto intend that there shall be added as a part of this Agreement a provision
as similar in terms to such invalid or unenforceable provision as may be possible and be valid and enforceable.

 

[Remainder of page intentionally left blank.
Signature page follows.]

 

    	 	14	 

     

    

 

IN WITNESS WHEREOF, the parties
hereto have caused this Agreement to be duly executed as of the date first above written.

 

	 	FINTECH ACQUISITION CORP. II
	 	 
	 	By: 	 /s/ James J. McEntee, III
	 	 	Name: James J. McEntee, III
	 	 	Title: President and Chief Financial Officer 

 

	 	CONTINENTAL STOCK TRANSFER & TRUST COMPANY, 
	 	as Warrant Agent 
	 	 
	 	By: 	 /s/ Isaac Kagan
	 	 	Name: Isaac Kagan
	 	 	Title: Account Administrator

 

[FinTech
II – Warrant Agreement]

 

     

     

    

 

 

EXHIBIT A

 

[Form of Warrant Certificate]

 

[FACE]

 

Number

 

Warrants

 

THIS WARRANT SHALL BE VOID IF NOT EXERCISED
PRIOR TO

 THE EXPIRATION OF THE EXERCISE PERIOD
PROVIDED FOR

 IN THE WARRANT AGREEMENT DESCRIBED BELOW

 

FINTECH ACQUISITION CORP. II

A Delaware corporation

 

CUSIP [ ]

 

Warrant Certificate

 

This Warrant Certificate
certifies that                     , or registered assigns, is the registered holder of                  warrant(s) (the “Warrants” and each,
a “Warrant”) to purchase shares of common stock, $0.0001 par value (the “Common Stock”),
of FinTech Acquisition Corp. II (the “Company”). Each Warrant entitles the holder, upon exercise during
the period set forth in the Warrant Agreement referred to below, to receive from the Company that number of fully paid and nonassessable
shares of Common Stock (each, a “Warrant”) as set forth below, at the exercise price (the “Exercise
Price”) as determined pursuant to the Warrant Agreement, payable in lawful money (or through “cashless
exercise” as provided for in the Warrant Agreement) of the United States of America upon surrender of this Warrant
Certificate and payment of the Exercise Price at the office or agency of the Warrant Agent referred to below, subject to the conditions
set forth herein and in the Warrant Agreement. Defined terms used in this Warrant Certificate but not defined herein shall have
the meanings given to them in the Warrant Agreement (as defined on the reverse hereof).

 

Each Warrant is initially
exercisable for one fully paid and non-assessable share of Common Stock; provided, however, that no fractional Warrant may be exercised
unless accompanies by other fractional Warrants that, in the aggregate, allow for the purchase of one full share of Common Stock
or an integral multiple thereof. The number of shares of Common Stock issuable upon exercise of the Warrants is subject to adjustment
upon the occurrence of certain events set forth in the Warrant Agreement. 

 

The initial Exercise Price
per share of Common Stock for any Warrant is equal to $11.50 per share. The Exercise Price is subject to adjustment upon the occurrence
of certain events set forth in the Warrant Agreement.

 

Subject to the conditions
set forth in the Warrant Agreement, the Warrants may be exercised only during the Exercise Period and to the extent not exercised
by the end of such Exercise Period, such Warrants shall become void.

 

Reference is hereby made
to the further provisions of this Warrant Certificate set forth on the reverse hereof and such further provisions shall for all
purposes have the same effect as though fully set forth at this place.

 

This Warrant Certificate
shall not be valid unless countersigned by the Warrant Agent, as such term is used in the Warrant Agreement.

 

     

     

    

 

This Warrant Certificate
shall be governed by and construed in accordance with the internal laws of the State of New York, without regard to conflicts of
laws principles thereof.

 

	 	FINTECH ACQUISITION CORP. II
	 	 
	 	By:	 
	 	 	Name: James J. McEntee, III 
	 	 	Title:   President and Chief Financial Officer 

 

	 	CONTINENTAL STOCK TRANSFER & TRUST COMPANY,
	 	as Warrant Agent 
	 	 
	 	By:	                  
	 	 	Name:
	 	 	Title: 

 

     

     

    

 

[Form of Warrant Certificate]

 

[REVERSE]

 

The Warrants evidenced by
this Warrant Certificate are part of a duly authorized issue of Warrants entitling the holder on exercise to receive shares of
Common Stock and are issued or to be issued pursuant to a Warrant Agreement dated as of January 19, 2017 (the “Warrant
Agreement”), duly executed and delivered by the Company to Continental Stock Transfer& Trust Company, a New York
corporation, as warrant agent (the “Warrant Agent”), which Warrant Agreement is hereby
incorporated by reference in and made a part of this instrument and is hereby referred to for a description of the rights, limitation
of rights, obligations, duties and immunities thereunder of the Warrant Agent, the Company and the holders (the words “holders” or
“holder” meaning the Registered Holders or Registered Holder) of the Warrants. A copy of the Warrant
Agreement may be obtained by the holder hereof upon written request to the Company. Defined terms used in this Warrant Certificate
but not defined herein shall have the meanings given to them in the Warrant Agreement.

 

Subject to the provisions
of the Warrant Agreement with respect to fractional Warrants, Warrants may be exercised at any time during the Exercise Period
set forth in the Warrant Agreement. The holder of Warrants evidenced by this Warrant Certificate may exercise them by surrendering
this Warrant Certificate, with the form of election to purchase set forth hereon properly completed and executed, together with
payment of the Exercise Price as specified in the Warrant Agreement (or through “cashless exercise” if
permitted by the Warrant Agreement) at the principal corporate trust office of the Warrant Agent. In the event that upon any exercise
of Warrants evidenced hereby the number of Warrants exercised shall be less than the total number of Warrants evidenced hereby,
there shall be issued to the holder hereof or his, her or its assignee, a new Warrant Certificate evidencing the number of Warrants
not exercised.

 

Notwithstanding anything
else in this Warrant Certificate or the Warrant Agreement, no Warrant may be exercised unless at the time of exercise (i) a
registration statement covering the shares of Common Stock to be issued upon exercise is effective under the Securities Act and
(ii) a prospectus thereunder relating to the shares of Common Stock is current, except through “cashless exercise”
if permitted by the Warrant Agreement. Additionally, if the Corporation fails to enter into a merger, capital stock exchange, asset
acquisition, stock purchase, reorganization or similar business combination, involving the Corporation and one or more businesses
by January 25, 2019, the Warrants evidenced by this Warrant Certificate shall expire worthless.

 

The Warrant Agreement provides
that, upon the occurrence of certain events, the number of the Warrants set forth on the face hereof may, subject to certain conditions,
be adjusted. If, upon exercise of a Warrant, the holder hereof would be entitled to receive a fractional interest in a share of
Common Stock, the Company shall, upon exercise, round down to the nearest whole number of shares of Common Stock to be issued to
the holder of the Warrant.

 

Warrant Certificates, when
surrendered at the principal corporate trust office of the Warrant Agent by the Registered Holder thereof in person or by legal
representative or attorney duly authorized in writing, may be exchanged, in the manner and subject to the limitations provided
in the Warrant Agreement, but without payment of any service charge, for another Warrant Certificate or Warrant Certificates of
like tenor evidencing in the aggregate a like number of Warrants.

 

Upon due presentation for
registration of transfer of this Warrant Certificate at the office of the Warrant Agent a new Warrant Certificate or Warrant Certificates
of like tenor and evidencing in the aggregate a like number of Warrants shall be issued to the transferee(s) in exchange for this
Warrant Certificate, subject to the limitations provided in the Warrant Agreement, without charge except for any tax or other governmental
charge imposed in connection therewith.

 

     

     

    

 

The Company and the Warrant
Agent may deem and treat the Registered Holder(s) thereof as the absolute owner(s) of this Warrant Certificate (notwithstanding
any notation of ownership or other writing hereon made by anyone), for the purpose of any exercise hereof, of any distribution
to the holder(s) hereof, and for all other purposes, and neither the Company nor the Warrant Agent shall be affected by any notice
to the contrary. Neither the Warrants nor this Warrant Certificate entitles any holder hereof to any rights of a stockholder of
the Company.

 

Election to Purchase

 

(To Be Executed Upon Exercise of Warrant)

 

The undersigned hereby irrevocably
elects to exercise the right, represented by this Warrant Certificate, to receive                  shares of Common Stock and herewith tenders payment
for such shares to the order of FinTech Acquisition Corp. II (the “Company”) in the amount of $                   in accordance
with the terms hereof. The undersigned requests that a certificate for such shares be registered in the name of               , whose address
is                  and that such shares be delivered to               whose address is                . If said number of shares is less than all of the shares of Common Stock
purchasable hereunder, the undersigned requests that a new Warrant Certificate representing the remaining balance of such shares
be registered in the name of                 , whose address is                , and that such Warrant Certificate be delivered to                  , whose address is                               .

 

In the event that the Warrant
has been called for redemption by the Company pursuant to Section 6 of the Warrant Agreement and the Company has required
cashless exercise pursuant to Section 6.3 of the Warrant Agreement, the number of shares that this Warrant is exercisable
for shall be determined in accordance with subsection 3.3.1(b) and Section 6.3 of the Warrant Agreement.

 

In the event that the Warrant
is a Placement Warrant that is to be exercised on a “cashless basis” pursuant to subsection
3.3.1(c) of the Warrant Agreement, the number of shares that this Warrant is exercisable for shall be determined in accordance
with subsection 3.3.1(c) of the Warrant Agreement.

 

In the event that the Warrant
is to be exercised on a “cashless basis” pursuant to Section 7.4 of the Warrant Agreement,
the number of shares that this Warrant is exercisable for shall be determined in accordance with Section 7.4 of the Warrant
Agreement.

 

In the event that the Warrant
may be exercised, to the extent allowed by the Warrant Agreement, through cashless exercise (i) the number of shares that
this Warrant is exercisable for would be determined in accordance with the relevant section of the Warrant Agreement which allows
for such cashless exercise and (ii) the holder hereof shall complete the following sentence: The undersigned hereby irrevocably
elects to exercise the right, represented by this Warrant Certificate, through the cashless exercise provisions of the Warrant
Agreement, to receive shares of Common Stock. If said number of shares is less than all of the shares of Common Stock purchasable
hereunder (after giving effect to the cashless exercise), the undersigned requests that a new Warrant Certificate representing
the remaining balance of such shares be registered in the name of, whose address is, and that such Warrant Certificate be delivered
to, whose address is ________.

 

Date:           , 20

 

	 	(Signature)
	 	 
	 	(Address)
	 	 
	 	(Tax Identification Number)

 

Signature Guaranteed:

 

THE SIGNATURE(S) SHOULD BE GUARANTEED BY AN
ELIGIBLE GUARANTOR INSTITUTION (BANKS, STOCKBROKERS, SAVINGS AND LOAN ASSOCIATIONS AND CREDIT UNIONS WITH MEMBERSHIP IN AN APPROVED
SIGNATURE GUARANTEE MEDALLION PROGRAM, PURSUANT TO S.E.C. RULE 17Ad-15).

 

     

     

    

 

EXHIBIT B

 

LEGEND

 

THE SECURITIES REPRESENTED HEREBY HAVE NOT BEEN
REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR ANY STATE SECURITIES LAWS AND NEITHER
THE SECURITIES NOR ANY INTEREST THEREIN MAY BE OFFERED, SOLD, TRANSFERRED, PLEDGED OR OTHERWISE DISPOSED OF EXCEPT PURSUANT TO
AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR SUCH LAWS OR AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES
ACT AND SUCH LAWS WHICH, IN THE OPINION OF COUNSEL FOR THIS CORPORATION, IS AVAILABLE.

 

THE SECURITIES REPRESENTED BY THIS CERTIFICATE
ARE SUBJECT TO RESTRICTIONS ON TRANSFER PURSUANT TO A LETTER AGREEMENT BETWEEN FINTECH ACQUISITION CORP. AND [CANTOR FITZGERALD
& CO.] [FINTECH INVESTOR HOLDINGS, LLC, AND THE DIRECTORS, OFFICERS AND CERTAIN STOCKHOLDERS OF FINTECH ACQUISITION CORP. II]
AND MAY ONLY BE OFFERED, SOLD, TRANSFERRED, PLEDGED OR OTHERWISE DISPOSED OF PURSUANT TO THE TERMS SET FORTH THEREIN.

 

	 	 	 
	No. 	 	 WarrantsExhibit 10.1

 

January
19, 2017

 

FinTech
Acquisition Corp. II

2929
Arch Street, Suite 1703

Philadelphia,
PA 19104-2870

New
York, New York 10019

 

	 	Re:	Initial
    Public Offering

 

Ladies
and Gentlemen:

 

This
letter (“Letter Agreement”), by and between FinTech Acquisition Corp. II, a Delaware corporation (the
“Company”), and Cantor Fitzgerald & Co. (“Cantor Fitzgerald”), is being
delivered in accordance with the Underwriting Agreement (the “Underwriting Agreement”) entered into,
or proposed to be entered into, by and between the Company and Cantor Fitzgerald, as the representative of the underwriters (the
“Underwriters”), relating to an underwritten initial public offering (the “Offering”),
of up to 17,595,000 of the Company’s units (the “Units”), each comprised of one share of the Company’s
common stock, par value $0.0001 per share (the “Common Stock”), and one-half of a warrant exercisable
for one share of Common Stock (each, a “Warrant”). The Units sold in the Offering will be registered
under the Securities Act of 1933, as amended (the “Securities Act”), pursuant to a registration statement on Form
S-1 and prospectus (the “Prospectus”) filed by the Company with the Securities and Exchange Commission
(the “Commission”). The Company expects that the Units will be listed for trading on the Nasdaq Capital
Market. Certain capitalized terms used herein are defined in paragraph 7 hereof.

 

Cantor
Fitzgerald hereby agrees with the Company as follows:

 

1.
         (a) Cantor Fitzgerald agrees to not propose any amendment to the Company’s amended and restated certificate of incorporation
that would affect the substance or timing of the Company’s obligation to redeem 100% of the Offering Shares if the Company
does not consummate a Business Combination within 24 months from the completion of the Offering, unless the Company provides the
holders of Offering Shares with the opportunity to redeem their Offering Shares upon approval of any such amendment at a per-share
price, payable in cash, equal to the aggregate amount then on deposit in the trust account, including any amounts representing
interest earned on the Trust Account less interest previously released to, or reserved for use by, the Company in an amount up
to $500,000 for working capital expenses and less any other interest released to, or reserved for use by, the Company to pay franchise
and income taxes, divided by the number of then outstanding Offering Shares.

 

(b)
Cantor Fitzgerald acknowledges and agrees that Placement Shares held by Cantor Fitzgerald are not entitled to, and have no right,
interest or claim of any kind in or to, any monies held in the Trust Account or distributed as a result of any liquidation of
the Trust Account, provided that nothing herein shall preclude Subscriber from making any claim or seeking recourse against the
funds held outside of the Trust Account or seeking payment of any deferred underwriting fee due and payable pursuant to the Underwriting
Agreement.

 

(c)
Cantor Fitzgerald waives, with respect to any Placement Shares that it holds, any redemption rights it may have (i) in connection
with the consummation of an initial Business Combination, (ii) if the Company fails to consummate its initial Business Combination
or liquidates within 24 months from the completion of the Offering or (iii) if the Company seeks an amendment to its amended and
restated certificate of incorporation that would affect the substance or timing of the Company’s obligation to redeem 100%
of the Offering Shares as described above. If Cantor Fitzgerald acquires Offering Shares in or after the Offering, Cantor Fitzgerald
shall have the same redemption rights as a public stockholder that acquired Offering Shares in the Offering with respect to such
Offering Shares.

 

     

     

    

 

2.

         (a) Until 30 days after the consummation of the initial Business Combination (“Placement Unit Lock-Up Period”),
Cantor Fitzgerald shall not, except as described in the Prospectus, (i) sell, offer to sell, contract or agree to sell, hypothecate,
pledge, grant any option to purchase or otherwise dispose of or agree to dispose of, directly or indirectly, or establish or increase
a put equivalent position or liquidate or decrease a call equivalent position within the meaning of Section 16 of the Exchange
Act of 1934, as amended, and the rules and regulations of the Commission promulgated thereunder (the “Exchange Act”)
with respect to the Placement Units, Placement Shares, Placement Warrants, or shares of Common Stock underlying the Placement
Warrants, (ii) enter into any swap or other arrangement that transfers to another, in whole or in part, any of the economic consequences
of ownership of any of the Placement Units, Placement Shares, Placement Warrants, or shares of Common Stock underlying the Placement
Warrants, whether any such transaction is to be settled by delivery of the Common Stock or such other securities, in cash or otherwise,
or (iii) publicly announce any intention to effect any transaction specified in clause (a)(i) or (a)(ii).

 

(b)
Notwithstanding the provisions contained in paragraph 2(a) hereof, Cantor Fitzgerald or any of its Permitted Transferees (as defined
below) may transfer the Placement Units, Placement Shares, Placement Warrants, or shares of Common Stock underlying the Placement
Warrants: (1) in connection with the Company’s initial Business Combination with the consent of the Company to any third
party that agrees in writing to be bound by the provisions of this agreement; and (2) (a) to the Company’s officers, the
Company’s directors, the Initial Holders or Cantor Fitzgerald’s officers, directors, equityholders (direct or indirect)
or other affiliates, (b) to an affiliate or immediate family member of any of the Company’s officers, directors or Initial
Holders, or Cantor Fitzgerald’s officers, directors and direct and indirect equityholders, (c) to any member, officer or
director of the Sponsor, or any immediate family member, partner, affiliate or employee of a member of the Sponsor, (d) by gift
to any permitted transferee under any of the immediately preceding subsections (a) through (c), a trust, the beneficiaries of
which are one or more permitted transferee under any of the immediately preceding subsections (a) through (c), or a charitable
organization, (e) by virtue of laws of descent and distribution upon death of any of the Company’s officers, the Company’s
directors, the Initial Holders, members of the Sponsor, or any officers, directors or direct or indirect equityholders of Cantor
Fitzgerald, (f) pursuant to a qualified domestic relations order, (g) in the event of the Company’s liquidation prior to
consummation of its initial Business Combination, (h) by virtue of the laws of Delaware, or the Sponsor’s limited liability
company agreement upon dissolution of the Sponsor or the organizational documents of Cantor Fitzgerald upon dissolution of Cantor
Fitzgerald, (i) subsequent to the Company’s consummation of its initial Business Combination, in the event of a liquidation,
merger, stock exchange or other similar transaction which results in all of the Company’s stockholders having the right
to exchange their shares of Common Stock for cash, securities or other property or (j) subsequent to the Company’s consummation
of its initial Business Combination, in the event of a consolidation, merger or other similar transaction in which the Company
is the surviving entity that results in the directors and officers of the Company ceasing to comprise a majority of the board
of directors (the “Board”) of the Company (in the case of directors) or management (in the case of officers)
of the surviving entity (each, a “Permitted Transferee”); provided, however, that, in the case of subclauses
(a) through (f) and (h), these transferees enter into a written agreement with the Company agreeing to be bound by the transfer
restrictions set forth herein.

 

(c)
Cantor Fitzgerald agrees that after the Placement Unit Lock-Up Period has elapsed, the Placement Units, Placement Shares, Placement
Warrants and shares of Common Stock underlying the Placement Warrants owned by Cantor Fitzgerald shall only be transferable or
saleable pursuant to a sale registered under the Securities Act or pursuant to an available exemption from registration under
the Securities Act. The Company and Cantor Fitzgerald each acknowledge that pursuant to that certain registration rights agreement
to be entered into among the Company, Cantor Fitzgerald, the Sponsor and the other parties thereto, the parties thereto may request
that a registration statement relating to the Placement Units, Placement Shares, Placement Warrants, or shares of Common Stock
underlying the Placement Warrants be filed by the Company with the Commission prior to the end of the Placement Unit Lock-Up Period;
provided, however, that such registration statement does not become effective prior to the end of the Placement Unit Lock-Up Period.

 

(d)
Subject to the limitations described herein, Cantor Fitzgerald shall retain all of Cantor Fitzgerald’s rights as a security
holder with respect to Placement Units and its underlying securities during the Placement Unit Lock-Up Period including, without
limitation, the right to vote Placement Shares.

 

(e)
During the Placement Unit Lock-Up Period, all dividends payable in cash with respect to such securities shall be paid, as applicable,
to each security holder, but all dividends payable in Common Stock or other non-cash property shall become subject to the applicable
lock-up period as described herein and shall only be released from such lock-up in accordance with the provisions of this paragraph
2.

 

    	 	2	 

     

    

 

3.
Without limiting the provisions of paragraph 2(b) hereof, during the period commencing on the effective date of the Underwriting
Agreement and ending 180 days after such date, Cantor Fitzgerald shall not (i) sell, offer to sell, contract or agree to sell,
hypothecate, pledge, grant any option to purchase or otherwise dispose of or agree to dispose of, directly or indirectly, or establish
or increase a put equivalent position or liquidate or decrease a call equivalent position within the meaning of Section 16 of
the Exchange Act and in compliance with FINRA Rule 5110(g) with respect to any Placement Units, Placement Shares or Placement
Warrants, (ii) enter into any swap or other arrangement that transfers to another, in whole or in part, any of the economic consequences
of ownership of any Placement Units, Placement Shares or Placement Warrants, whether any such transaction is to be settled by
delivery of such securities, in cash or otherwise, or (iii) publicly announce any intention to effect any transaction specified
in clause (i) or (ii), except to any Permitted Transferee in accordance with FINRA Rule 5110(g)(2).

 

4.
The Company agrees that the Company will not engage any third party to render services, agree to purchase any products from
such third party, or enter into any discussion or any acquisition agreement with a prospective target business (a “Target”)
unless (i) such third party or Target has agreed to execute a waiver against any right, title, interest or claim of any kind in
or to any monies held in the Trust Account or any proceeds from the Trust Account, that is acceptable to the Board or (ii) the
Board has consented in writing to dispense with such waiver with respect to such services, product, discussions or acquisition
agreement, in each case with the written consent of the Indemnitor as part of the consent of the Board.

 

5.
Intentionally Omitted.

 

6.
The Company and Cantor Fitzgerald each acknowledges and agrees that the Company will not consummate any initial Business Combination
that involves a company which is affiliated with Cantor Fitzgerald unless the Company obtains an opinion from an independent investment
banking firm that is a member of the Financial Industry Regulatory Authority and reasonably acceptable to Cantor Fitzgerald that
the Business Combination is fair to the Company’s stockholders from a financial perspective.

 

7.
As used in this Letter Agreement, (i) “Business Combination” shall mean a merger, capital stock
exchange, asset acquisition, stock purchase, reorganization or similar Business Combination, involving the Company and one or
more businesses; (ii) “Initial Holders” shall mean Daniel G. Cohen, Betsy Z. Cohen, DGC Family FinTech
Trust, Swarthmore Trust of 2016, Shami Patel, James J. McEntee, III, Jeremy Kuiper and the Sponsor; (iii) “Offering
Shares” shall mean the shares of Common Stock included in the units sold in the Offering; (iv) “Placement
Shares” shall mean the shares of Common Stock sold as part of the Placement Units; (v) “Placement Warrants”
shall mean the Warrants to purchase up to an aggregate of 210,000 shares of the Common Stock that are included in the Placement
Units; (vi) “Placement Units” shall mean the aggregate of 420,000 Units of the Company (each Placement
Unit consists of one-half of one Placement Warrant and one Placement Share) sold in the Private Placement to the Sponsor and Cantor
Fitzgerald for an aggregate purchase price of $4,200,000; (vii) “Trust Account” shall mean the trust
account into which net proceeds of the Offering and the Private Placement will be deposited; (viii) “Prospectus”
shall mean the prospectus included in the registration statement filed by the Company in connection with the Offering, as supplemented
or amended from time to time; (ix) “Private Placement” shall mean that certain private placement transaction
occurring simultaneously with the closing of the Offering pursuant to which the Company has agreed to sell an aggregate of 420,000
Placement Units to FinTech Investor Holdings II, LLC, a Delaware limited liability company (the “Sponsor”)
and Cantor Fitzgerald; and (x) references to completion of the Offering shall exclude any exercise of the Underwriters’
over-allotment option.

 

8.
This Letter Agreement constitutes the entire agreement and understanding of the parties hereto in respect of the subject matter
hereof and supersedes all prior understandings, agreements, or representations by or among the parties hereto, written or oral,
to the extent they relate in any way to the subject matter hereof or the transactions contemplated hereby. This Letter Agreement
may not be changed, amended, modified or waived (other than to correct a typographical error) as to any particular provision,
except by a written instrument executed by the parties hereto.

 

9.
No party may assign either this Letter Agreement or any of its rights, interests, or obligations hereunder without the prior
written consent of the other party. Any purported assignment in violation of this paragraph shall be void and ineffectual and
shall not operate to transfer or assign any interest or title to the purported assignee. This Letter Agreement shall be binding
on each undersigned party and each of such undersigned party’s, as applicable, heirs, personal representatives, successors
and assigns.

 

    	 	3	 

     

    

 

10.
This Letter Agreement shall be governed by and construed and enforced in accordance with the laws of the State of New York
applicable to contracts entered into within the borders of such state and without giving effect to conflicts of law principles
that would result in the application of the substantive laws of another jurisdiction. The parties (i) agree that any action, proceeding,
claim or dispute arising out of, or relating in any way to, this Letter Agreement shall be brought and enforced in the federal
or state courts in the borough of Manhattan in the City of New York, and irrevocably submits to such jurisdiction and venue, which
jurisdiction and venue shall be exclusive and (ii) waive any objection to such exclusive jurisdiction and venue or that such courts
represent an inconvenient forum.

 

11.
Any notice, consent or request to be given in connection with any of the terms or provisions of this Letter Agreement shall
be in writing and shall be sent by express mail or similar private courier service, by certified mail (return receipt requested),
by hand delivery, electronic or facsimile transmission.

 

12.
This Letter Agreement shall terminate in the event that the Offering is not completed by April 30, 2017.

 

[Signature
page follows]

 

    	 	4	 

     

    

 

	 	Sincerely,
	 	 
	 	FINTECH
        ACQUISITION CORP. II

        a
        Delaware corporation

         

	 	By:	/s/
James J. McEntee, III
	 	Name:	James
    J. McEntee, III
	 	Title:	President
    and Chief Financial Officer

 

	 	CANTOR
        FITZGERALD & CO.

        a
        New York general partnership

 

	 	By:	/s/
Shawn Matthews
	 	Name:	Shawn
    Matthews
	 	Title:	CEO

 

[Signature
Page to Letter Agreement – Cantor]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00266-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00266-of-00352.parquet"}]]